{"id":"https://openalex.org/W560844622","doi":null,"title":"Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline","display_name":"Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline","publication_year":1991,"publication_date":"1991-05-13","ids":{"openalex":"https://openalex.org/W560844622","mag":"560844622"},"language":"en","primary_location":{"id":"mag:560844622","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA1208360X","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112066093","display_name":"John P. Feighner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John P. Feighner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109036554","display_name":"William F. Boyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William F. Boyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8029,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.86486486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":0.9700000286102295},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":1.0},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5720000267028809},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.906000018119812},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.847000002861023},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9679999947547913},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8130000233650208},{"id":"https://openalex.org/keywords/clinical-application","display_name":"clinical application","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.8292142152786255},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.7543113231658936},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.752869725227356},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6556150913238525},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.621522068977356},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.5844365358352661},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5452223420143127},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44039100408554077},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37392762303352356},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.32568663358688354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2716894745826721},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.24991697072982788},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.24186167120933533},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0797383189201355}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:560844622","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA1208360X","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W581211420","https://openalex.org/W1881287185","https://openalex.org/W3027753663","https://openalex.org/W3197356922","https://openalex.org/W4416949088","https://openalex.org/W2247831691","https://openalex.org/W1504665000","https://openalex.org/W7217655391","https://openalex.org/W2400996873","https://openalex.org/W2076639163"],"abstract_inverted_index":{"The":[0],"neuropharmacology":[1],"of":[2,14,42,54,79,90],"serotonin":[3,16,23,44,56,72,82,93],"in":[4,19,47,59],"the":[5,10,22,40,52,80,91],"central":[6],"nervous":[7],"system,":[8],"C.A.Marsden":[9],"comparative":[11],"pharmacological":[12],"properties":[13],"selective":[15,43,55,71,81,92],"re-uptake":[17,45,57,73,83,94],"inhibitors":[18,46,58],"animals,":[20],"A.M.Johnson":[21],"hypothesis":[24],"-":[25],"necessary":[26],"but":[27],"not":[28],"sufficient,":[29],"W.F.Boyer":[30,37,49,64,75,85,96],"and":[31,34,38,50,61,76,86],"J.P.Feighner":[32,39,51,77,87],"pharmacokinetics":[33],"drug":[35],"interactions,":[36],"efficacy":[41,53],"depression,":[48],"anxiety":[60],"obsessive-compulsive":[62],"disorder,":[63],"et":[65,97],"al":[66],"other":[67],"potential":[68],"indications":[69],"for":[70],"inhibitors,":[74,84,95],"side-effects":[78],"clinical":[88],"use":[89],"al.":[98]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}